在无病存活率方面没有统计上显著差异。
No statistically significant difference was shown for disease free survival.
观察两组患者的临床疗效、组织学疗效、对化疗的毒副反应，以及术后3年生存率和无病存活率，并进行对比分析。
The clinical and histological effects, toxic and side reaction of chemotherapy such as nausea and vomit, the 3-year survival rates and disease-free survival rates were analyzed.
这些报告表明，即使在短期内跟进一年赫赛汀导致改善无病，转移自由和整体存活率。
These reports showed that even after short term follow up one year of Herceptin resulted in improved disease free, metastases free and overall survival.
应用推荐